Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

Rx Price Hikes In Advance Of Health Bill Will Get OIG Probe

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Sen. Bill Nelson continues campaign to extract more concessions from pharmaceutical industry as part of health care reform legislation.

You may also be interested in...



OIG's 2012 Agenda Includes Several New Part D, Part B Drug Issues

OIG's 2012 Agenda Includes Several New Part D, Part B Drug Issues

Medicaid Drug Rebates Offset Price Increases For Brands During 2005-2009, OIG Concludes

Despite substantial price inflation, rebate-adjusted Medicaid payments for all branded drugs increased by only 2% over the four years in the study.

Table

View full table

Related Content

Pink Sheet
Pink Sheet
Pink Sheet
Pink Sheet

Topics

Tags:
BioPharmaceutical
Latest Headlines

Final ICH Guide Supports Nonclinical Development Of Gene Therapy Products

NICE Confirms English Funding For Three COVID-19 Drugs, But Rejects Four Others

Canadian Action On Rare Disease Is A ‘Step Forward,’ Says Industry

Three Firms Sign Up With MPP For Long-Acting Cabotegravir

See All
UsernamePublicRestriction

Register

PS068920

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By